Shape memory polymer foams to seal space around valves
Shape memory polymer foam is used to seal around prosthetic heart valves, addressing paravalvular leakage by expanding to fill gaps and integrate with tissue, providing a durable seal against blood leakage.
Patent Information
- Application Number
- JP2024110719
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2017-03-14
- Filing Date
- 2024-07-10
- Publication Date
- 2024-11-06
- Estimated Expiration
- 2038-03-14
AI Technical Summary
Paravalvular or paraprosthetic leak (PVL) is a common complication associated with the implantation of prosthetic heart valves, particularly affecting the mitral valve, leading to leakage of blood through channels between the implanted valve structure and heart tissue, with an incidence of up to 20%.
The use of shape memory polymer (SMP) foam to fill the space around the valve, promoting tissue integration and sealing, which expands radially to block leakage and facilitate integration with surrounding tissue, using thermal stimuli or body temperature for expansion.
The SMP foam effectively blocks leakage around the valve, promotes tissue integration, and provides a sustainable seal by forming a thrombus that is replaced by integrated tissue over time, reducing paravalvular leakage.
Smart Images

Figure 2024156683000001_ABST
Abstract
Description
[Technical field]
[0001] PRIORITY: This application claims priority to U.S. Provisional Patent Application No. 6 / 471,131, entitled “Shape Memory Polymer Foams to Seal Space Around Valves,” filed March 14, 2017, the contents of which are incorporated herein by reference. TECHNICAL FIELD: The present invention relates to the medical device field, in particular to valves. [Background technology]
[0002] Surgery to replace a heart valve (e.g., aortic or mitral) is performed for a variety of reasons, including mitral, aortic, pulmonary, or tricuspid stenosis or regurgitation. In this procedure, the damaged valve is removed and replaced with an artificial valve. The valve replacement procedure is usually open-heart surgery; however, patients also have the option of minimally invasive surgery or placing a catheter in place of the valve. An artificial valve may be mechanical (made from artificial materials) or made from animal tissue. Summary of the Invention
[0003] Paravalvular or paraprosthetic leak PVL is a complication associated with the implantation of prosthetic heart valves, either by conventional (surgical) or transcatheter (TAVI) approaches. Paravalvular or paraprosthetic leak refers to the leakage of blood through a channel between the implanted valve structure and the heart tissue as a result of an improper seal. Most PVLs are crescent, elliptical or circular in shape, with parallel, perpendicular or serpentine trajectories. The incidence of PVL, including small, non-significant ejections, is estimated to be as high as 20%. PVL is also more common in the mitral valve (up to 20%) than in the aortic valve.
[0004] Features and advantages of embodiments of the present invention will become apparent from the appended claims, the following detailed description of one or more exemplary embodiments, and the associated drawings, in which: Where considered appropriate, reference labels in the figures have been repeated to indicate corresponding or analogous elements. [Brief description of the drawings]
[0005] [Figure 1] In one embodiment, the stent comprises a shape memory polymer (SMP) foam substantially covering the fenestrations.
[0006] [Diagram 2] A shows a radially compressed SMP foam in one embodiment, and B shows a radially expanded SMP foam.
[0007] [Diagram 3] 1A shows a radially compressed SMP foam in one embodiment, and B shows the radially compressed foam and stent after compression of the stent for delivery to a patient.
[0008] [Figure 4] In one embodiment, a radiopaque monolithic SMP foam ring is included, which also illustrates the machinability (i.e., ability to form the foam into a variety of shapes and sizes) for that embodiment.
[0009] [Diagram 5] A shows a low density foam matrix in one embodiment. B shows a high density foam doped with radio-opacity.
[0010] [Figure 6] A shows the expanded SMP foam. B shows the SMP foam as it is pressed / compressed. C shows the SMP foam as it is pressed / compressed.
[0011] [Figure 7]Various shapes and sizes are shown that demonstrate the machining capabilities of the embodiments. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0012] Reference is now made to the drawings, in which similar structures may be provided with similar reference symbols at the end. The drawings contained herein are schematic diagrams, and more clearly show the structure of various embodiments. Thus, the actual appearance of a manufactured structure, for example in a photograph, may appear different, while still incorporating the claimed structure of the illustrated embodiment. Furthermore, the drawings may show only structures that are useful for understanding the illustrated embodiment. Additional structures known in the art may not be included to maintain the clarity of the drawings. Terms such as "embodiments," "various embodiments," and the like refer to the described embodiments, but not all embodiments necessarily include a particular feature, structure, or characteristic.
[0013] Some embodiments may have some or all of the features described with respect to other embodiments. Terms such as "first," "second," "third," and the like, describe a common object and also indicate different instantiations of the similar object being referenced. Such adjectives do not imply that the described objects are described in a given sequence, or temporal, spatial, ordering, or otherwise. The term "connected" may indicate that elements are in direct physical or electrical contact with each other, and "coupled" may indicate that elements cooperate or interact with each other, but that they may or may not be in direct physical or electrical contact.
[0014] Many of the embodiments discussed herein relate to perivalvular leaks, but the embodiments relate more generally to leaks involving implanted valves, whether they be heart valves, peripheral venous valves, or other valves.
[0015] Applicants have attempted to use conventional materials, such as PET (Dacron) "skirts" to fill the paravalvular space and promote tissue integration. However, Applicants have further found that the techniques do not adequately volumetrically fill the perivalvular space or promote tissue integration. In the embodiments described herein, shape memory polymer (SMP) foam is used to fill the perivalvular space and promote tissue integration.
[0016] For example, one embodiment includes the use of SMP foams incorporated around the annulus of a heart valve to reduce flow around the valve and promote integration of the device into the surrounding tissue. More specifically, the SMP foams expand to fill the gaps around the valve that may be improperly fixed, have an abnormal cross-section, or have poor apposition to the calcified lesion. For example, radial expansion of the foam provides volumetric filling around the device. This applies to surgically implanted valves, and the shape memory capabilities of the foams are particularly useful for intravascular valve delivery.
[0017] While many of the embodiments herein relate to radial compression of the SMP foam (and subsequent radial expansion of the SMP foam), other embodiments may use axial compression / expansion and / or circumferential compression / expansion.
[0018] Once implanted, the foam seals perivalvular leakage and promotes tissue integration to achieve sustained occlusion. The porous morphology of the foam promotes acute thrombosis and sealing of the device. Over time, the thrombus is replaced by integrated tissue, providing a sustainable seal and integration of the device into the surrounding tissue.
[0019] One embodiment includes a monolithic foam annulus bonded to the valve. See, for example, the foam annulus in FIG. 4. Bonding can include weaving valve support struts through the foam (see, for example, FIG. 1), bonding the valve support struts to the foam, and / or coating the valve support struts with a polymer (such as polyurethane) film and bonding the foam to the polymer film. Attaching the foam to the valve support structure ensures that the foam does not fall off or migrate downstream and occlude the blood vessel.
[0020] As shown in FIG. 2B, one embodiment includes a closed cell "scale" that is adhered to the device.
[0021] In one embodiment, Nitinol wires are threaded through a polymer foam (see Figures 1 and 3A). The wire structures are threaded through the foam and then bonded together to form a support structure.
[0022] In one embodiment, the bottom of the SMP "scale" is not bonded to the Nitinol frame (see Figures 1, 3A and 3B). For foam "scale" embodiments, the anisotropic strain (see, e.g., Figure 3B) is adjusted to accommodate the valve support structure during radial compression within the delivery catheter. For example, the windows of the support structure contract along the circumferential axis (see, e.g., the "horizontal" arrow in Figure 3A, which shows the Nitinol window movement), but expand axially (see, e.g., the "vertical" arrow in Figure A, which shows the Nitinol window movement). In other words, the bottom of the scale is free and does not experience significant tension that could cause the foam to burst.
[0023] In one embodiment, the SMP "scale" includes windows (see top voids of the SMP foam in Figure 1) for welding together adjacent support struts.
[0024] Other scales include Figures 5A, 5B, 6A, 6B, 6C, and 7. The foam shape factors shown in Figures 5A-7 represent different degrees of area filling within each "window" of the support structure. Varying the foam shape factor can change the degree of radial compression and folding of the scale after compression. When a flat foam scale is radially compressed, it folds similarly to a catheter balloon, minimizing the crimped cross-sectional area that is properly positioned during delivery.
[0025] While many of the above embodiments relate to sealing valves, and in particular heart valves, other embodiments may be, but are not limited to, sealing abdominal aortic aneurysm (AAA) stent grafts, and the like.
[0026] One embodiment includes foams obtained by reacting one or more polyols (e.g., HPED and / or TEA) with one or more diisocyanates (e.g., hexamethylene diisocyanate (HDI), trimethylhexamethylene diisocyanate (TMHDI), and / or isophorone diisocyanate) to form polyurethane SMPs. Embodiments include HDI, TMHDI, isophorone diisocyanate, triethanolamine, diethanolamine, butanediol, butynediol, N, Examples include polyurethane SMP foams synthesized by several combinations of N,N',N' tetrakis(hydroxypropylene)ethylenediamine.
[0027] Other embodiments include X-ray visible SMP foams. For example, one embodiment includes foams obtained by reacting one or more polyols (e.g., 5-amino-2,4,6-triiodoisophthalic acid; 3-methyl-1,5-pentanediol; 2-butyl-2-ethyl-1,3-propanediol; hexanetriol; butanetriol) with one or more diisocyanates (e.g., HDI) to form polyurethane SMPs.
[0028] The embodiments provide various means for ensuring protection of the foam during transport of the device.
[0029] In one embodiment, the valve is delivered through a large diameter catheter / sheath, which allows for a large delivery "ramrod" (which can accommodate significant friction from the inflation device) from which the valve is deployed. Because the foam is bonded to a support structure (e.g., the foam may be bonded to struts or locally bonded across the entire area of the window), the foam does not shear during delivery.
[0030] In some transcatheter embodiments, the expansion of the foam is delayed. For example, the device can be stored well below body temperature and programmed for rapid expansion time once body temperature is reached (which may be above the wet Tg of the foam). The foam can be stored in its moisture plasticized state.
[0031] Surgical implantation (as opposed to transcatheter implantation) may operate at or above body temperature for the foam.
[0032] In some embodiments (eg, transcatheter or surgical implantation), the foam is expanded with warm saline at the end of preparation.
[0033] When using foam instead of a traditional Dacron skirt, one embodiment is to have the foam in a lubricious sheath (e.g., a sheath made of PTFE) that the surgeon removes when ready to deploy the device, which would minimize shear forces on the foam given that, for example, PTFE is slippery / less resistant than many PU catheters.
[0034] Embodiments include low and / or high density foams. In embodiments, density is used to balance the mechanical strength of the foam (e.g., higher density reduces foam crimping ability) with minimizing crimp diameter (e.g., higher density reduces shear / tear). One embodiment includes foams with pore sizes between 50 and 1500 microns.
[0035] In some embodiments, the foam never expands into the main vessel. For example, the foam is sufficiently adhered to the support structure to expand radially abluminally. The foam attached to the valve must not damage the ventricle. For example, in one embodiment, a mechanical restraint is used to prevent the foam from expanding radially inward into the main vessel. For example, a valve may prevent the foam from expanding inward. As another example, a polymeric membrane placed between the foam and the inner channel of the device may prevent the foam from expanding inward.
[0036] Embodiments may include scales that are not all identical. For example, one embodiment may include multiple rows of scales, some of which may be half-scale and others full-scale. The rows may be interchanged within the scale and / or between scale magnitudes for two different patterns.
[0037] In one embodiment, a Dacron skirt and an SMP foam are used together, for example, the Dacron skirt acts like a "sheath" that folds over the crimped foam to facilitate delivery.
[0038] Some embodiments may be used in different pressure environments (e.g., venous versus arterial pressure), and may use different pore sizes / formation factors.
[0039] Embodiments may also address perivalvular leakage in venous valve replacement devices, such as the vena cava.
[0040] FIG. 1 includes a system 100 having a stent including first, second, third, and fourth struts 101, 102, 103, 104. The stent further includes first, second, third, fourth, and fifth fenestrations 111, 112, 113, 114, 115. A valve 121 is contained within the stent (best seen in FIG. 2B). An outer conduit includes an open cell polyurethane thermoset SMP foam 131 configured to expand from a compressed secondary state to an expanded primary state in response to a thermal stimulus. In FIG. 1, the first and third fenestrations 111, 113 share the first strut 101 and are both directly adjacent to the first strut. The second and third fenestrations 112, 113 share the second strut 102 and are both directly adjacent to the second strut. The fourth and third fenestrations 113, 113 share the third strut 103 and are both directly adjacent to the third strut. The fifth and third windows 115, 113 share the fourth strut 104 and are both immediately adjacent to the fourth strut. Although struts 101, 103 may be contained in a single monolithic length of wire, which constitutes other "struts", the term refers to "struts" as used herein.
[0041] In Figure 1, the SMP foam 131 substantially covers at least 80% of the first face of the third window. This "face" is perhaps 95% (or more) obscured in the embodiment of Figure 1, with the face being primarily formed by the posts 101, 102, 103, 104.
[0042] In one embodiment, the first, second, third, and fourth struts each include a shape memory metal such as Nitinol. However, other embodiments are not limited thereto and may include stainless steel or other metals. The non-shaped memory metal may be deployed by a balloon or other expandable device. Other embodiments include a surgically implanted valve.
[0043] In Figure 1, the first and second struts 101, 102 rigidly connect the SMP foam, while the third and fourth struts 103, 104 do not rigidly connect the SMP foam. The applicability of this arrangement extends as follows: foam 131 may contact strut 103, but is not "fixed" to it, and does not necessarily move with it when strut 103 distorts due to stent elongation. However, foam 131 is fixed to strut 101 and moves with strut 101 movement. In other words, the movement of foam 131 is dependent on strut 101 and not on strut 103.
[0044] In a first orientation (e.g., when the system is in its packaging for shipment to a medical facility), the outer diameter of the stent is a first maximum outer stent diameter. As shown in Figure 3B, the length of the fenestrations 313 (similar to the fenestrations 113 in Figure 1) is a first fenestrations length 341 measured parallel to the long axis 341 of the stent. The fenestrations are also perpendicular to the long axis of the stent, and the length of the fenestrations is a first fenestrations width 342' measured parallel to the short axis 343 of the stent. The SMP foam 331 is in a compressed secondary state.
[0045] In the second direction, the outer diameter of the stent is a second maximum outer stent diameter 342 that is greater than the first maximum outer stent diameter 342'. This is because the stent is compressed (possibly crimped) and the trajectory of the stent is reduced (in a stent ready for implantation). In that case, the stent is elongated along axis 341 and necked (constricted) along axis 343. As a result, the fenestrations 313 have a second fenestrations length 340 that is less than the first fenestrations length 340'. Also, the width of the fenestrations 313 is a second fenestrations width 342 that is greater than the first fenestrations width 342'. The SMP foam is in an expanded primary state in the second direction.
[0046] In contrast to the change in length of window 313, the body length of SMP foam 331 is the same (at least in some embodiments) in the compressed and expanded states. For example, length 344' is substantially the same (+ / - 3%) as length 344. In some embodiments, the width of the foam may be the same in the compressed and expanded states (although the width appears to change in Figures 3A and 3B, in some embodiments, the width of the foam does not change). It is considered to keep the length and width of the foam consistent before folding or creasing of the system occurs. In some embodiments, foam 331 is compressed only radially (into the page in Figure 3A), with little or no compression / expansion in the axial (along axis 341) or circumferential (generally along axis 343) directions.
[0047] Applicant has noted that the existence of such "crimping dynamics" and the issue of metal stents being more deformable (i.e., axially) than SMP foams are important. Applicant has further noted that metals such as Nitinol have a relatively low strain capacity (e.g., 4%), while SMP foams have a relatively high strain capacity. That is, if a metal stent is significantly deformed axially (along axis 341), the deformation may be greater than the axial deformation of the SMP foam. For example, the SMP foam may have little or no axial deformation. Thus, a radially compressed SMP foam may not be deformed to the extent of metal window length difference 340'' (340'-340=340''). In various embodiments, the axial extension of the foam may be 0, 5, 10, 15, or 20% of axial difference 340''.
[0048] In response to such crimping dynamics, one embodiment secures foam 331 to some struts of the stent but not to other struts. For example, in FIG. 1, SMP foam 131 fixedly connects struts 101, 102 at locations 151, 151' and 152, 152'. At locations 151, 151' and 152, 152', struts 101, 102 repeatedly penetrate SMP foam 131 to secure foam 131 to the stent. In other words, strut 101 penetrates SMP foam 131 at least one location (e.g., location 151) such that a first strut traverses from a first face of the SMP foam (the front face in FIG. 1) to a second face of the SMP foam (the rear face not visible in FIG. 1) such that the first and second faces face each other. Note that the bottom half of the SMT foam 131 is not fixedly attached to the posts 103, 104. In response to the first and second posts 101, 102 that are fixedly connected to the SMP foam 131 and the third and fourth posts 103, 104 that are not fixedly connected to the SMP foam, the SMP foam is configured to move in response to the first and second posts and moves independently of the third and fourth posts when the device transitions from the first orientation to the second orientation. For example, in Figures 3A and 3B, the foam 331 will move up and down (or up and down along axis 341) when the posts 301, 302 move up and down along axis 341. However, excessive downward deflection by the posts 303, 304 will not break or damage the cells of the SMT foam 331 because the foam is largely independent of the movement of the posts 303, 304.
[0049] Regarding the connection of the foam 131 to the various struts, the SMT foam can be connected to the stent in other ways. For example, in one embodiment, an adhesive (e.g., UV epoxy welds using Dymax 203A-CTH-F to connect the Nitinol struts to the polyurethane of the SMP foam) connects the SMP foam 131 to the first and second struts 101, 102. The adhesive may be applied along lengths 161, 162, but is not present in lengths 161', 162', nor is it present on struts 103, 104. The adhesive is not visible in FIG. 1 because it is between the foam 131 and the struts. Masking may be used in areas 161', 162', 103, 104 to ensure that no adhesive is applied thereto. The masking (e.g., oxide or nitride) may be removed later in the process in some embodiments.
[0050] In one embodiment, the adhesive includes an unfoamed polyurethane coating that is in direct contact with and fixedly attached to the first strut 101. The SMP foam 131 is in direct contact with and fixedly adheres to the polyurethane coating. As a result, the polyurethane coating fixedly adheres the SMP foam 131 to the first strut 101. Thus, when the polyurethane foam adheres to other polyurethanes, the bond between the adhesive and the foam becomes stronger. For example, the unfoamed polyurethane coating can be neat polyurethane.
[0051] In one embodiment, the polyurethane coating is a cured thermoset. However, in other embodiments, the polyurethane coating is a thermoplastic. According to one embodiment, the chemical composition of the polyurethane coating is identical to that of the SMP foam. Therefore, the adhesion between the foam and the adhesive is "like to like" and therefore reliable. For example, both the SMP foam and the adhesive coating may be obtained from a reaction between one or more polyols (e.g., HPED and / or TEA) and one or more diisocyanates (e.g., hexamethylene diisocyanate (HDI), trimethylhexamethylene diisocyanate (TMHDI), and / or isophorone diisocyanate).
[0052] In one embodiment, the polyurethane coating is an SMP. The chemical composition of the SMP coating can be the same as the chemical composition of the SMP foam. In one embodiment, the SMP coating is foamed to provide a first foam (inner foam) that connects a second foam (outer foam 131) to the stent struts.
[0053] Further regarding the construction of foam 131, in one embodiment, the SMP foam is covalently bonded with iodine to form a foam that is visible under x-ray imaging (i.e., radiopacity). Also regarding radiopacity, in one embodiment, the SMP foam is a poly(urethane-urea-amide). In one embodiment, the iodine includes triiodobenzene monomer.
[0054] As noted above, in the compressed state, foam 131 is radially compressed along radius 155, which is perpendicular to both stent major axis 141 and stent minor axis 143. This is better seen in Figures 2A (compressed) and 2B (radially expanded).
[0055] In various embodiments, one or more foam segments are used in various ways.
[0056] For example, in Figure 1, SMP foam 131 substantially covers a majority of the surface of window 113, but does not cover a majority of the surface of any of the first, second, fourth, and fifth windows 111, 112, 114, and 115. In the embodiment of Figure 1, window 113 is directly adjacent each of the first, second, fourth, and fifth windows 111, 112, 114, and 115. There are no other stent windows between window 114 and any of windows 111, 112, 114, and 115.
[0057] For example, Figure 2A discloses SMP foam 131. Additionally, Figure 2A includes an additional open-cell polyurethane thermoset SMP foam 132 configured to expand from a compressed secondary state to an expanded primary state in response to a thermal stimulus. Foam 132 substantially covers a first side of fourth window 215, the fourth window having opposing first and second sides. At least a portion of fourth strut 104 fixedly connects additional SMP foam 132 (but not foam 131). In a first direction, the additional SMP foam is in a compressed secondary state, and in a second direction, the additional SMP foam is in an expanded primary state.
[0058] In one embodiment, foam 131 may be expanded slightly such that foam 131 extends to boundary 131' such that the expanded SMP foam 131 and the further SMP foam 132 overlap each other (see area 133 for the area of overlap) and an axis (see dot 155' indicating the axis into the page) intersects both the SMP foam 131 and the further SMP foam 132. Axis 155' is perpendicular to the stent major axis 141 and the stent minor axis 143.
[0059] As seen in Figure 2A, SMP foam 131 has a first surface area. Further foam 132 has a second surface area. The first surface area is at least 20% greater than the second surface area. However, in other embodiments, one foam segment may have a surface area 30, 40, 50, 60, 70, 80, 90% or more greater than the other foam segment.
[0060] In the embodiment of FIG. 2B, foam 131 coexists with foam 135. The additional open-cell polyurethane thermoset SMP foam 135 is configured to expand from a compressed secondary state to an expanded primary state in response to a thermal stimulus. The additional SMP foam 135 substantially covers a first side of a sixth window 216 included in the stent, the sixth window having a first and second opposing sides. The other SMP foam 135 does not substantially cover the third window 113. The SMP foam 131 does not substantially cover the sixth window 216. Additional struts 201 are included in the sixth window 216 to rigidly connect the additional SMP foam 135 (similar to how struts 101 connect foam 131). In a first direction, the additional SMP foam 135 is in a compressed secondary state, and in a second direction, the additional SMP foam is in an expanded primary state.
[0061] 1, a first plane 157 parallel to the stent minor axis 143 intersects the SMP foam 131, the first and second struts 101, 102, and the first, second and third fenestrations 111, 112, 113. A second plane 158 parallel to the stent minor axis intersects the SMP foam 131, the third and fourth struts 103, 104, and the third, fourth and fifth fenestrations 113, 114, 115. The first plane 157 does not intersect either the third or fourth struts 103, 104. The first plane 157 does not intersect either the fourth or fifth fenestrations 114, 115. The second plane 158 does not intersect either the first or second struts 101, 102. The second plane 158 does not intersect either the first fenestrations 111 or the fenestrations 112.
[0062] In the embodiment of Figure 1, a first strut 101 connects to a second strut 102 at a first joint 108. An axis 109 (see dots going into the page) intersects the first joint but does not contact the SMP foam 131. The axis 109 is perpendicular to the long axis 141 of the stent and the short axis 143 of the stent. As described above, the strut 101 may be "attached" through the foam 131 and then the struts 101, 102 are connected (e.g., welded) to one another. Thus, a window or gap with side walls 107, 107' may be formed such that the connection (e.g., welding) can occur without interference from the existing foam 131.
[0063] With respect to the "outer conduit" above, embodiments may use a conduit (e.g., tube, sheath, skirt, catheter) to deploy the foam / stent system. In one embodiment, the outer conduit may include polytetrafluoroethylene (PTFE), extruded PTFE (ePTFE), or other relatively low friction material that limits shear forces in the SMP foam.
[0064] Some embodiments may include other conduits in addition to or instead of the "outer conduit" described above. For example, one embodiment may include an inner conduit (such as a polyurethane membrane) between the valve and the SMP foam. For example, a Dacron skirt (or any of the various polymer skirts / conduits in various embodiments such as a polyurethane skirt) may be between the valve and the stent and may function to ensure that the SMP foam does not expand within the main vessel (e.g., the aorta). In other embodiments, an inner conduit may be between the stent and the SMP foam. An adhesive may connect the foam to the inner conduit. The inner conduit may be connected to the struts. In this way, the foam is connected to the struts via the adhesive and the inner conduit. In one embodiment, an unfoamed SMP adhesive bonds the SMP foam (which is of the same chemical composition as the adhesive) to a non-shape memory inner conduit (e.g., a polyurethane inner conduit) that is connected to the stent.
[0065] As shown in FIG. 4, one embodiment includes an SMP foam that includes a monolithic SMP foam ring. The SMP foam ring may be on the outside of the stent and surround the stent. The ring may include folds or pleats that facilitate controlled and repeatable collapse of the ring when the stent is folded to minimize the implanted profile. Portions of the top half of the ring may be secured to the struts, while the bottom half of the ring may not be secured to the struts, so that the bottom half is not overstretched when the stent is axially stretched. The embodiment of FIG. 4 may be small and suitable for peripheral vessels (e.g., valves for veins), while other embodiments may be large to surround heart valves, etc.
[0066] The following examples relate to further embodiments.
[0067] Example 1: A device comprising: (a)(i) a stent including first, second, third, and fourth struts and (a)(ii) first, second, third, fourth, and fifth fenestrations; a valve contained within the stent; a cellular polyurethane thermoset shape memory polymer (SMP) foam, the SMP foam configured to expand from a compressed, secondary state to an expanded, primary state in response to a thermal stimulus; and an outer conduit, wherein; (b)(i) (b)(ii) the first and third windows share the first strut and are both directly adjacent to the first strut, (b)(iii) the second and third windows share the second strut and are both directly adjacent to the second strut, (b)(iii) the fourth and third windows share the third strut and are both directly adjacent to the third strut, and (b)(iv) the fifth and third windows share the fourth strut and are both directly adjacent to the fourth strut; the third window has first and second opposing faces, and the SMP foam is covering substantially at least 80% of a first surface of the three fenestrations; (c)(i) the first and second struts rigidly connect the SMP foam, while (c)(ii) the third and fourth struts do not rigidly connect the SMP foam; in a first orientation, (d)(i) the stent has a first stent maximum outer diameter, (d)(ii) the third fenestrations have a first fenestrations length measured parallel to a longitudinal axis of the stent, and (d)(iii) the third fenestrations have a first fenestrations length measured perpendicular to a longitudinal axis of the stent, in a second direction, (e)(i) the stent has a second maximum external stent diameter that is greater than the first maximum external stent diameter, (e)(ii) the third fenestrations have a second fenestrations length that is less than the first fenestrations length, (e)(iii) the third fenestrations have a second fenestrations width that is greater than the first fenestrations width, and (e)(iv) the SMP foam is in the expanded primary state;and in response to the first and second struts rigidly connecting the SMP foam and the third and fourth struts not rigidly connecting the SMP foam, the SMP foam is configured to move reliant on the first and second struts but independent of the third and fourth struts when the device transitions from the first orientation to the second orientation;
[0068] In other embodiments, the SMP foam substantially covers at least 50, 60, 70, 90% of the first surface of the third window.
[0069] In another aspect of Example 1, a device is provided that includes: (a)(i) a stent including first, second, third, and fourth struts, and (a)(ii) first, second, third, fourth, and fifth fenestrations; a valve contained within the stent; a cellular polyurethane thermoset shape memory polymer (SMP) foam, the SMP foam configured to expand from a compressed secondary state to an expanded primary state in response to a thermal stimulus; and an outer conduit, wherein; (b)(i) the (b)(ii) the second and third windows share the second strut and are both directly adjacent to the second strut, (b)(iii) the fourth and third windows share the third strut and are both directly adjacent to the third strut, and (b)(iv) the fifth and third windows share the fourth strut and are both directly adjacent to the fourth strut; the third windows have first and second opposing sides, and the SMP foam is substantially at least partially adjacent to the first side of the third windows. at least 80% of the stent body; the first, second, third, and fourth struts each comprise a shape memory metal; (c)(i) the first and second struts fixedly connect the SMP foam, while (c)(ii) the third and fourth struts do not fixedly connect the SMP foam; in a first orientation, (d)(i) the stent has a first maximum stent outer diameter, (d)(ii) the third fenestrations have a first fenestrations length measured parallel to a longitudinal axis of the stent, and (d)(iii) the third fenestrations have a first fenestrations length measured perpendicular to a longitudinal axis of the stent, in a second direction, (e)(i) the stent outer diameter has a second maximum stent outer diameter that is greater than a first maximum stent outer diameter, (e)(ii) the third fenestrations have a second fenestrations length that is less than the first fenestrations length, (e)(iii) the third fenestrations have a second fenestrations width that is greater than the first fenestrations width, and (e)(iv) the SMP foam is in the expanded primary state;and in response to the first and second struts rigidly connecting the SMP foam and the third and fourth struts not rigidly connecting the SMP foam, the SMP foam is configured to move reliant on the first and second struts but independent of the third and fourth struts when the device transitions from the first orientation to the second orientation;
[0070] In another aspect of Example 1, a device includes: (a)(i) a stent including first, second, third, and fourth struts, and (a)(ii) first, second, third, fourth, and fifth fenestrations; a valve contained within the stent; an open cell polyurethane thermoset shape memory polymer (SMP) foam, the SMP foam having been expanded from a compressed secondary state to an expanded primary state; and an outer conduit including the stent; wherein (b)(i) the first and third fenestrations share the first strut and are both directly adjacent to the first strut, (b)(ii) the second and third fenestrations share the second strut and are both directly adjacent to the second strut, (b)(iii) the fourth and third fenestrations share the third strut and are both directly adjacent to the third strut, and (b)(iv) the fifth and third fenestrations share the fourth strut and are both directly adjacent to the fourth strut; the third fenestrations have first and second opposing faces. the SMP foam substantially covers at least 80% of a first surface of the third fenestrations; (c)(i) the first and second struts rigidly connect the SMP foam, but (c)(ii) the third and fourth struts do not rigidly connect the SMP foam; in a first orientation, (d)(i) the stent has a first maximum stent outer diameter, (d)(ii) the third fenestrations have a first fenestrations length measured parallel to a major axis of the stent, and (d)(iii) the third fenestrations have a first fenestrations width measured perpendicular to the major axis of the stent and parallel to a minor axis of the stent; in a second orientation, (e)(i) the stent has a second maximum stent outer diameter that is greater than the first maximum stent outer diameter, (e)(ii) the third fenestrations have a second fenestrations length that is less than the first fenestrations length, and (e)(iii) the third fenestrations have a second fenestrations width that is greater than the first fenestrations width.
[0071] Thus, in some embodiments, the product may be shipped with the SMP foam already transitioned from a compressed state to a non-compressed state (eg, already plasticized).
[0072] Although some embodiments discussed herein address windows and posts, the embodiments are not limited to any one form of support structure. Metal or polymer support frameworks are viable options that can benefit from SMP foams to reduce or prevent PVL. Additionally, a lower half portion of the SMP foam can be bonded to a support structure, whereas an upper half portion of the SMP foam is not bonded to a support structure. This allows the support structure to be extended (as an example) without damaging the radially compressed SMP foam.
[0073] Although the examples have dealt with the transition of SMP foams to a primary state in response to thermal stimuli, SMP foams can be stimulated based on body heat, warm saline solution, electromagnetic stimuli via fields delivered externally or internally, light from a fiber optic cable, interaction with an electric current delivered through a wire in close proximity to the foam, etc.
[0074] In some embodiments, the SMP foam may be replaced with a hydrogel.
[0075] Example 2: The device of example 1, wherein in the compressed state, the first foam is radially compressed along a radius that is both perpendicular to the major axis of the stent and the minor axis of the stent.
[0076] Example 3: The device of Example 2, wherein the length of the SMP foam in a compressed state is a length of a first foam, the length of the first foam being measured parallel to the longitudinal axis of the stent; and the length of the SMP foam in an expanded state is a length of a second foam, the length of the first foam being substantially equal to the length of the second foam.
[0077] Example 4: The apparatus of Example 2, wherein the first support penetrates the SMP foam in at least one location transversely from a first surface of the SMP foam to a second surface of the SMP foam, and the first and second surfaces oppose one another.
[0078] Example 5: The device of Example 2, wherein the first strut connects to the second strut at a first junction; an axis intersects the first junction but does not contact the SMP foam; the axis is perpendicular to the major axis of the stent; and the axis is perpendicular to the minor axis of the stent.
[0079] Example 6: The apparatus of Example 2 including an adhesive connecting the SMP foam to the first and second struts.
[0080] Example 7: The apparatus of Example 6, wherein the adhesive includes an unfoamed polyurethane coating fixedly adhered to and in direct contact with the first strut; the SMP foam fixedly adhered to and in direct contact with the polyurethane coating; and wherein the polyurethane coating fixedly adheres the SMP foam to the first strut.
[0081] Example 8: The device of Example 7, wherein the polyurethane coating is a cured thermoset.
[0082] Example 9: The device of Example 7, wherein the polyurethane coating is thermoplastic.
[0083] Example 10: The device described in Example 7, wherein the chemical composition of the polyurethane coating is equal to that of the SMP foam.
[0084] Example 11: The device described in Example 10, where the polyurethane coating is an SMP.
[0085] Example 12: The apparatus of Example 6 including an inner conduit between the valve and the SMP foam.
[0086] For example, the inner conduit may include a thermoplastic polyurethane membrane that is deposited onto the stent struts. The SMP foam may then be adhered to the membrane with an adhesive. As noted above, the adhesive may include polyurethane. That is, one embodiment includes a polyurethane adhesive that adheres the polyurethane SMP foam to the polyurethane membrane (where the membrane is adhered to the stent).
[0087] Example 13: The apparatus of Example 2, wherein the outer conduit is made of polytetrafluoroethylene (PTFE).
[0088] Example 14: A device as described in Example 2, wherein the SMP foam is covalently bonded to iodine.
[0089] Example 15: The device of Example 14, wherein the SMP foam is a poly(urethane-urea-amide).
[0090] Example 16: The apparatus of example 14, wherein the iodine is contained in a triiodobenzene monomer.
[0091] Example 17: The apparatus of example 2, wherein the SMP foam is obtained by reaction of one or more polyols with one or more diisocyanates.
[0092] Example 18: The device of Example 2, wherein the SMP foam substantially covers a majority of a first side of the third window but does not cover a majority of a side of any of the first, second, fourth, and fifth windows; the third window is directly adjacent each of the first, second, fourth, and fifth windows; and there are no other stent windows between the third window and any of the first, second, fourth, and fifth windows.
[0093] Example 19: an additional open cell polyurethane thermoset SMP foam configured to expand from a compressed secondary state to an expanded primary state in response to a thermal stimulus; wherein said additional SMP foam covers a first side of said fourth window, said first side and second side being substantially opposed to one another; said third strut fixedly connects said additional SMP foam; In the first direction, the further SMP foam is in the compressed secondary state; in the second direction, the further SMP foam is in the expanded primary state.
[0094] Example 20: The device of example 19, wherein the SMP foam and the further SMP foam overlap one another such that an axis intersects the SMP foam and the further SMP foam together; the axis is perpendicular to the major axis of the stent; and the axis is perpendicular to the minor axis of the stent.
[0095] The device of Example 2, wherein an additional open-cell polyurethane thermoset SMP foam is configured to expand in response to a thermal stimulus from a compressed secondary state to an expanded primary state; wherein the additional SMP foam substantially covers a first side of a sixth window included in the stent, the sixth window having opposing first and second sides; the additional SMP foam does not substantially cover the third window; the SMP foam does not substantially cover the sixth window; additional struts included in the sixth window fixedly connect the additional SMP foam; in the first direction, the additional SMP foam is in the compressed secondary state; and in the second direction, the additional SMP foam is in the expanded primary state.
[0096] Example 22: The apparatus of example 21, wherein the surface area of the SMP foam is a first surface area; the surface area of the further foam is a second surface area; and the first surface area is at least 20% greater than the second surface area.
[0097] While Example 22 addresses the example of different scales or sizes of SMP foam segments, other examples include SMP foam segments with different densities, compression, porosity, etc. For example, a higher density foam may be directly adjacent to the valve annulus while being sandwiched axially by a lower density foam, allowing the higher density foam to withstand lift forces not present in areas removed from the valve annulus.
[0098] Example 23: The device of Example 2, wherein the SMP foam comprises a monolithic SMP foam ring; the SMP foam ring is external to the stent and surrounds the stent.
[0099] Example 24: The device of Example 2, wherein a first plane parallel to the short axis of the stent intersects the SMP foam, the first and second struts, and the first, second, and third windows; a second plane parallel to the short axis of the stent intersects the SMP foam, the third and fourth struts, and the third, fourth, and fifth windows; the first plane does not intersect either the third or fourth struts; the first plane does not intersect either the fourth or fifth window; the second plane does not intersect either the first strut or the second strut; and the second plane does not intersect either the first or second window.
[0100] Example 25: The device of example 2, wherein the first, second, third, and fourth struts each comprise at least one of nitinol, cobalt chrome, and stainless steel.
[0101] Example 26: A device comprising: a metal scaffold including first, second, third, and fourth struts; a valve contained within the scaffold; an open cell polyurethane thermoset shape memory polymer (SMP) foam configured to expand from a compressed secondary state to an expanded primary state in response to a thermal stimulus, wherein: (a)(i) the first and second struts fixedly connect the SMP foam, and (a)(ii) the third and fourth struts do not fixedly connect the SMP foam; in a first orientation, (b)(i) the stent has a first maximum outer stent diameter, (b)(ii) the stent has a first stent length measured parallel to a longitudinal axis of the stent, and (b)(iii) the SMP foam is in the compressed secondary state; in a second orientation, (c)(i) the stent has a second maximum outer stent diameter that is greater than the first maximum outer stent diameter, (c)(ii) the stent has a second stent length that is shorter than the first stent length; (c)(iii) the SMP foam is in the expanded primary state; in response to the first and second struts fixedly connecting the SMP foam and the third and fourth struts not fixedly connecting the SMP foam, the SMP foam is configured to move dependently on the first and second struts but independent of the third and fourth struts when the device transitions from the first orientation to the second orientation; a first plane perpendicular to a longitudinal axis of the stent intersects the SMP foam and the first and second struts; a second plane perpendicular to a longitudinal axis of the stent intersects the SMP foam and the third and fourth struts; the first plane does not intersect either of the third or fourth struts; and the second plane does not intersect either of the first or second struts.
[0102] Example 1a: A device comprising: a structural support scaffold comprising first, second, third, and fourth struts; a valve contained within the scaffold; an open cell polyurethane thermoset shape memory polymer (SMP) foam configured to expand from a compressed secondary state to an expanded primary state in response to a thermal stimulus, wherein: (a)(i) the first and second struts fixedly connect the SMP foam, and (a)(ii) the third and fourth struts do not fixedly connect the SMP foam; in a first orientation, (b)(i) the stent has a first maximum outer stent diameter, (b)(ii) the stent has a first stent length measured parallel to a longitudinal axis of the stent, and (b)(iii) the SMP foam is in the compressed secondary state; and in a second orientation, (c)(i) the stent has a second maximum outer stent diameter that is greater than the first maximum outer stent diameter. (c)(ii) the stent has a second stent length that is shorter than the first stent length; and (c)(iii) the SMP foam is in the expanded primary state; in response to the first and second struts fixedly connecting the SMP foam and the third and fourth struts not fixedly connecting the SMP foam, the SMP foam is configured to move dependently on the first and second struts but independent of the third and fourth struts when the device transitions from the first orientation to the second orientation; a first plane perpendicular to a longitudinal axis of the stent intersects the SMP foam and the first and second struts; a second plane perpendicular to a longitudinal axis of the stent intersects the SMP foam and the third and fourth struts; the first plane does not intersect either of the third or fourth struts; and the second plane does not intersect either of the first or second struts.
[0103] Thus, not all scaffolds are metal: some may be made of polymers, etc.
[0104] Example 2a: The apparatus of Example 1a, wherein an adhesive is in direct contact with the first and second struts and the SMP foam, directly adhering the SMP foam to each of the first and second struts; but neither the third nor fourth struts are in direct contact with adhesive which is in direct contact with the SMP foam.
[0105] Example 3a: The device of Example 1a, including a membrane in contact with the first and second struts, where a location within the top half of the SMP foam is directly adhered to the membrane via an adhesive that is in direct contact with the membrane and the SMP foam; and a bottom half of the SMP foam is not directly adhered to the membrane via any adhesive and is configured to slide on the membrane when the device transitions from a first orientation to a second orientation.
[0106] Example 4a: The device of any one of Examples 1a-3a, wherein in the compressed state, the first foam is radially compressed along a radius that is both perpendicular to the major axis of the stent and the minor axis of the stent.
[0107] Example 5a: The SMP foam is a first foam in a compressed state, the length of the first foam being measured parallel to the longitudinal axis of the stent; the length of the SMP foam in an expanded state is the length of a second foam; the length of the first foam is substantially equal to the length of the second foam. The apparatus described in Example 4a.
[0108] Example 6a: The device of Example 4a, wherein the first post penetrates the SMP foam in at least one location transversely from a first surface of the SMP foam to a second surface of the SMP foam, and the first and second surfaces oppose one another.
[0109] Example 7a: The device of Example 4a, wherein the first strut connects to the second strut at a first junction; an axis intersects the first junction but does not contact the SMP foam; the axis is perpendicular to the major axis of the stent; and the axis is perpendicular to the minor axis of the stent.
[0110] Example 8a: The apparatus of Example 1a including an adhesive connecting the SMP foam to the first and second struts.
[0111] Example 9a: The apparatus of any of Examples 2a-8a, wherein the adhesive includes an unfoamed polyurethane coating fixedly adhered to and in direct contact with the first strut; the SMP foam is fixedly adhered to and in direct contact with the polyurethane coating; and wherein the polyurethane coating fixedly adheres the SMP foam to the first strut.
[0112] Example 10a: The device of Example 9a, wherein the polyurethane coating is a cured thermoset.
[0113] Example 11a: A device as described in Example 9a, where the polyurethane coating is thermoplastic.
[0114] Example 12a: The device of Example 9a, wherein the chemical composition of the polyurethane coating is equal to the chemical composition of the SMP foam.
[0115] Example 13a: The device of Example 12a, wherein the polyurethane coating is an SMP.
[0116] Example 14a: The apparatus of Example 4a, including an inner conduit between the valve and the SMP foam.
[0117] For example, the inner conduit may include a thermoplastic polyurethane membrane that is deposited onto the stent struts. The SMP foam may then be adhered to the membrane with an adhesive. As noted above, the adhesive may include polyurethane. That is, one embodiment includes a polyurethane adhesive that adheres the polyurethane SMP foam to the polyurethane membrane (where the membrane is adhered to the stent).
[0118] Example 15a: The apparatus of Example 4a, wherein the outer conduit comprises polytetrafluoroethylene (PTFE).
[0119] Example 16a: A device as described in Example 4a, wherein the SMP foam is covalently bonded to iodine.
[0120] Example 17a: The device of Example 16a, wherein the SMP foam is a poly(urethane-urea-amide).
[0121] Example 18a: The apparatus of example 16a, wherein the iodine is contained in a triiodobenzene monomer.
[0122] Example 19a: The device according to example 4a, wherein the SMP foam is obtained by reaction of one or more polyols with one or more diisocyanates.
[0123] Example 20a: The device of Example 4a, wherein the SMP foam substantially covers a majority of a first side of the third window, but does not cover a majority of a side of any of the first, second, fourth, and fifth windows; the third window is directly adjacent each of the first, second, fourth, and fifth windows; and there are no other stent windows between the third window and any of the first, second, fourth, and fifth windows.
[0124] Example 21a: The apparatus of Example 21a, further comprising an open-cell polyurethane thermoset SMP foam configured to expand in response to a thermal stimulus from a compressed secondary state to an expanded primary state; wherein the further SMP foam covers a first side of the fourth window, the first side and second side being substantially opposed to one another; the third strut fixedly connects the further SMP foam; in the first direction the further SMP foam is in the compressed secondary state; and in the second direction the further SMP foam is in the expanded primary state.
[0125] Example 22a: The device of Example 21a, wherein the SMP foam and the further SMP foam overlap one another such that an axis intersects the SMP foam and the further SMP foam together; the axis is perpendicular to the major axis of the stent; and the axis is perpendicular to the minor axis of the stent.
[0126] Example 23a is the device of Example 4a, wherein an additional open-cell polyurethane thermoset SMP foam is configured to expand in response to a thermal stimulus from a compressed secondary state to an expanded primary state; wherein the additional SMP foam substantially covers a first side of a sixth window included in the stent, the sixth window having opposing first and second sides; the additional SMP foam does not substantially cover the third window; the SMP foam does not substantially cover the sixth window; additional struts included in the sixth window fixedly connect the additional SMP foam; in the first direction, the additional SMP foam is in the compressed secondary state; and in the second direction, the additional SMP foam is in the expanded primary state.
[0127] Example 24a: The apparatus of Example 23a, wherein the surface area of the SMP foam is a first surface area; the surface area of the further foam is a second surface area; and the first surface area is at least 20% greater than the second surface area.
[0128] Example 25a: The device of Example 4a, wherein the SMP foam comprises a monolithic SMP foam ring; the SMP foam ring is exterior to and surrounds the stent.
[0129] Example 26a: The device of example 4a, wherein the first, second, third, and fourth struts each comprise at least one of nitinol, cobalt chrome, and stainless steel.
[0130] The above description of the embodiments of the invention has been presented for purposes of illustration and description. The precise form of the disclosure is not exhaustive and the invention is not limited thereto. The present specification and claims include terms used for descriptive purposes only, such as left, right, top, bottom, on top, bottom, first, second, etc., which should not be construed as limiting. For example, terms indicating a relative vertical position refer to a situation in which a side of a substrate is the "top" surface of the substrate, and the substrate may actually be in any orientation, such that the "top" side of the substrate is lower than the "bottom" side of a standard reference frame and still be within the meaning of the term "top". The term "on" in this specification (and in the claims) does not indicate that a first layer "on" a second layer is directly on or in direct contact with the second layer, unless otherwise specified, and there may be a third layer or other structure between the first and second layers. The embodiments of the device or product described herein may be manufactured, used, or shipped in numerous configurations and orientations. Those skilled in the art will appreciate that many modifications and variations are possible in light of the above teachings. Those skilled in the art will recognize various equivalent combinations and permutations of the various components illustrated in the drawings. Accordingly, it is intended that the scope of the invention be limited not by this detailed description, but rather by the claims appended hereto.
Claims
1. a valve support structure comprising at least one of a metal or a polymer; A valve contained within the valve support structure; and Polyurethane shape memory polymer (SMP) foam; An apparatus comprising: (a)(i) a first half of the SMP foam is fixedly bonded to a first portion of the valve support structure; and (a)(ii) no portion of a second half of the SMP foam is fixedly bonded to a second portion of the valve support structure; In a first direction, (b)(i) the valve support structure has a first maximum outer diameter, and (b)(ii) the valve support structure has a first length measured parallel to a longitudinal axis of the valve support structure; in a second orientation, (c)(i) the valve support structure has a second maximum outer diameter that is greater than the first maximum outer diameter, and (c)(ii) the valve support structure has a second length that is less than the first length; a first half of the SMP foam is fixedly coupled to the first portion of the valve support structure and no portion of the second half of the SMP foam is fixedly coupled to the second portion of the valve support structure, such that when the device transitions from the first orientation to the second orientation, the SMP foam moves dependent on the first portion of the valve support structure but independent of the second portion of the valve support structure; a first plane perpendicular to a longitudinal axis of the valve support structure intersects the SMP foam and the first portion of the valve support structure; a second plane perpendicular to the longitudinal axis of the valve support structure intersects the SMP foam and the second portion of the valve support structure; the first plane does not intersect the second portion of the valve support structure; and the second plane does not intersect the first portion of the valve support structure. Device.
2. The device of claim 1 comprising a membrane.
3. The device of claim 2 , wherein a membrane is between the valve and the SMP foam.
4. The device of claim 2 , wherein a membrane is between the valve support structure and the SMP foam.
5. The device of any one of claims 2 to 4, wherein the membrane comprises a polymer.
6. The device of any one of claims 2 to 4, wherein the membrane comprises a skirt.
7. The apparatus of claim 6 , wherein a skirt is folded over the SMP foam.
8. The device according to any one of claims 2 to 7, wherein the SMP foam is fixedly adhered to the membrane by an adhesive.
9. An apparatus according to any one of claims 2 to 8, wherein a membrane fixedly bonds the first half of the SMP foam to the first portion of the valve support structure.
10. The apparatus of any one of claims 1 to 9, wherein the SMP foam comprises a monolithic SMP foam ring.
11. The apparatus of claim 10 , wherein the monolithic SMP foam ring includes folds, pleats, or a combination thereof.
12. 12. The device of claim 10 or 11, wherein a monolithic SMP foam ring surrounds the valve.
13. An apparatus according to any preceding claim, comprising a further polyurethane SMP foam overlying the SMP foam.
14. 13. The apparatus of claim 1, comprising a plurality of said SMP foam bodies, said plurality of SMP foam bodies including said SMP foam body and said plurality of SMP foam bodies surrounding a valve.
15. An apparatus according to any one of claims 1 to 14, comprising the valve support structure, a valve, and a conduit comprising the SMP foam.
16. 16. The apparatus of any one of claims 1 to 15, wherein a second half of the SMP foam contacts a second portion of the valve support structure.
Citation Information
Patent Citations
Improved stent used for stent graft
JP2002191700A
Tubular vascular implant (STENT) and method for producing the same
JP2008272492A
Low-profile transcatheter heart valves
JP2011522634A
Stent graft delivery system with tip capture mechanism with elongated cable for progressive deployment and repositioning
JP2016511042A
Valve assembly with a bioabsorbable gasket and a replaceable valve implant
US20130190865A1
